Altace and Difficulty in walking - a phase IV clinical study of FDA data

Summary:

Difficulty in walking is reported as a side effect among people who take Altace (ramipril), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Zocor, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Difficulty in walking when taking Altace. It is created by eHealthMe based on reports of 23,086 people who have side effects when taking Altace from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Difficulty in walking?

Difficulty in walking is found to be associated with 731 drugs and 977 conditions by eHealthMe. Check the latest studies of Difficulty in walking.

On Jul, 17, 2026

23,086 people reported to have side effects when taking Altace.
Among them, 80 people (0.35%) have Difficulty in walking.

Could Altace cause Difficulty in walking?

Among these 80 people:

How long have people been on Altace when they have Difficulty in walking? *

What is the gender of people who have Difficulty in walking when taking Altace? *

female: 67.5 %
male: 32.5 %

What is the age of people who have Difficulty in walking when taking Altace? *

What are other drugs people take besides Altace? *

What are other side effects people have besides Difficulty in walking? *

Weakness: 30 people, 37.50%
Joint Pain: 15 people, 18.75%
Dizziness: 13 people, 16.25%
Swallowing Difficulty: 12 people, 15.00%
Fatigue (feeling of tiredness): 12 people, 15.00%
Back Pain: 9 people, 11.25%
Pain: 9 people, 11.25%
Rashes (redness): 9 people, 11.25%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 10.00%
Pain In Extremity: 8 people, 10.00%

What are the existing conditions these people have? *

High Blood Cholesterol: 7 people, 8.75%
Osteoporosis (bones weak and more likely to break): 3 people, 3.75%
Aggression: 2 people, 2.50%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 2 people, 2.50%
Joint Pain: 2 people, 2.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 2.50%
Pain: 2 people, 2.50%
Stable Angina (a constant chest pain): 2 people, 2.50%
Arthropathy: 2 people, 2.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and have Difficulty in walking?

- Check whether Difficulty in walking is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Altace:

Altace (23,681 reports)

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Difficulty in walking:

Difficulty in walking (731 drugs)

Browse all the conditions that are associated with Difficulty in walking:

Difficulty in walking (977 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Altace) and Altace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.